ARD1 Use of ARD1 as a Liver cancer diagnostic marker

摘要

Hepatocellular carcinoma (HCC) progresses gradually, and dysplastic nodules that develop in chronic liver disease, especially hyperdifferentiated dysplastic nodules, are precancerous lesions and can be seen as early changes in the development of multilevel hepatocellular carcinoma. Because the malignant progresses gradually through the dysplastic nodule stage, it develops into hepatocellular carcinoma with a high degree of metastasis and a poor degree of differentiation. Recently, efforts have been focused on early diagnosis of liver cancer. Accordingly, the present invention relates to a liver cancer diagnosis step and a liver cancer diagnosis kit so that the liver cancer can be diagnosed and predicted effectively at an early stage. The analysis of the level of ARD1 expression according to the present invention enables early diagnosis and response of liver cancer, It is expected that it will be useful for understanding.